Several studies have suggested that p16INK4a hypermethylation could be used as a biomarker in the prediction of malignant transformation, due to the methylation-associated metastasis and poor survival in HNSCC [77]. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.